Related Experiment Video
Updated: May 2, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Measuring in vitro induction of antigen-specific CD8+ T-cell responses by murine conventional dendritic cells
Mo D Staal1, Douwe M T Bosma1, Jannie Borst1
1Department of Immunology and Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands.
Insights
Researchers developed a new in vitro platform to study how type 1 conventional dendritic cells (cDC1s) interact with CD8+ T-cells. This method overcomes limitations in studying these crucial immune cells for tumor immunology and vaccine development.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Type 1 conventional dendritic cells (cDC1s) are critical for initiating CD8+ T-cell responses.
- Studying cDC1-CD8+ T-cell interactions is challenging due to cDC1 scarcity and difficulty in in vitro propagation.
- Conventional dendritic cell models derived from bone marrow or monocytes do not fully replicate ex vivo properties.
Purpose of the Study:
- To establish a controlled in vitro platform for studying CD8+ T-cell priming by primary cDC1s.
- To enable mechanistic studies on cDC1-CD8+ T-cell communication using physiologically relevant models.
- To facilitate research in tumor immunology and vaccine development by providing a reproducible system.
Main Methods:
- Isolation of primary cDC1s from spleens of B16-FLT3L tumor-bearing mice.
- Development of an in vitro co-culture system for CD8+ T-cell priming.
- Utilizing debris from cells undergoing various modes of cell death to stimulate the system.
- Incorporating readouts for cDC status and phagocytic activity.
Main Results:
- The platform successfully enables readout of CD8+ T-cell proliferation and cytotoxic effector differentiation.
- The system responds to cellular debris from tumor cells undergoing different cell death pathways.
- The methodology proves reproducible and physiologically relevant for studying cDC-T-cell interactions.
Conclusions:
- The developed in vitro platform overcomes key limitations in studying cDC1-CD8+ T-cell communication.
- This approach provides a valuable tool for advancing research in tumor immunology and vaccine design.
- The system offers broad applications for investigating immune responses in various contexts.
Abstract:
Type 1 conventional dendritic cells (cDC1s) play a central role in directing CD8+ T-cell responses. Mechanistic studies on cDC1-CD8+ T-cell communication are hindered by the scarcity of cDC1s and their inability to be propagated in vitro. Furthermore, dendritic cells derived from bone marrow or monocytes generally lack phenotypic and functional properties of ex vivo cDC1s. Here, we present a controlled in vitro CD8+ T-cell priming platform based on the isolation of ex vivo primary cDCs from spleens of B16-FLT3L tumor-bearing mice. This system enables read out of CD8+ T-cell proliferation and cytotoxic effector differentiation in response to debris from (tumor) cells that die by different modes of cell death. The set up can also be modified to include read outs for cDC status and phagocytic activity. Our approach establishes a reproducible and physiologically relevant method to study cDC-T-cell interactions in vitro, with broad applications in tumor immunology and vaccine development.
More Related Videos
08:39An In Vivo Mouse Model to Measure Naïve CD4 T Cell Activation, Proliferation and Th1 Differentiation Induced by Bone Marrow-derived Dendritic Cells
Published on: August 22, 2018
09:51Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
Published on: May 18, 2018